Hyperbaric oxygen therapy (HBOT) increases blood flow and transports more oxygen through the plasma to the inner ear and nerve cells, thus reducing hypoxia. HBOT has been shown to reduce inflammation and promote stem cell growth and mobilization. It is also bacteriocidal.
The cochlea and the structures within it require a high oxygen supply. HBOT dissolves extra oxygen into the plasma. Tissue oxygenation to these structures occurs via oxygen diffusion from cochlear capillary networks into the perilymph and corilymph. Perilymph oxygen tension decreases significantly with sudden sensorineural hearing loss (ISSHL). Although normobaric hyperoxygenation increases intracochlear oxygen tensions, only HBOT achieves extremely high arterial perilymphatic oxygen concentration in human and animal studies.
Patients who present with ISSHL, within 14 days and have a moderate or greater severity 40dB are the most likely to improve according to studies. However, The American Academy of Otolaryngology Head and Neck Foundation recommends considering treatment up to three months from the symptom onset.
Our experience reflects the studies. Early intervention with HBOT yields the greatest improvement. Additionally, we have also had some success with patients getting HBOT between the 14 to 90 day window of onset. See Clinical Practice Guideline: Sudden Hearing Loss Article below.
HBOT Treatment Recommendation
For sudden hearing loss, most physicians recommend 100% oxygen at 2-2.5 ATA for 90 minutes daily for 10-20 treatments. All patients have to return to their ENT to be tested to know for sure how much of their hearing they have regained. Most patients respond slowly, and some do not notice changes until they are near the end of their treatments. And there are those unfortunate few who do not regain their hearing even after all their treatments. There are some who regain enough hearing so they can hear with the use of a hearing aid.
As a provider, your office fills out and faxes back the Patient Referral Form. Have questions? Call us!
We make sure the patient understands treatment and then follow the prescribed protocol to get the patient on the road to recovery!
Our medical staff meets with the patient to ensure that HBOT is appropriatre, and contacts Medicare or private insurance to receive authorization.
Hyperbaric medicine, also called hyperbaric oxygen therapy or HBOT, is a medical treatment where a patient sits or lies in pressurized chamber and breathes 100% oxygen. In HBOT, oxygen dissolves into the blood, thus raising the oxygen concentration to very high levels.This increased oxygen is a primary building block for tissues, muscle, and bone repair. Among other benefits, it kicks off cell reproduction, heals injuries and infection more rapidly, and decreases inflammation.
Hyperbaric treatments help heal neuropathy by regrowing small blood vessels and nerves that have died from disease, injuries from radiation and aging. Patients often experience numbness and or pain when they start treatment. Hyperbaric treatments most often bring back sensation and make, for example, walking easier and more enjoyable.
Current research indicates that hyperbaric oxygen does not kill cancer cells. However, there has been a small amount of research indicating that hyperbaric oxygen might reduce the size of certain tumors. Also, there has been a study on mice using hyperbaric oxygen, along with a ketogenic diet, to reduce tumors. Hyperbaric oxygen causes many different healing modalities to kick into gear. Could its effect on strengthening the immune system inhibit the growth of cancer cells? Nobody knows. There are numerous studies conclusively showing that hyperbaric oxygen does not encourage cancer cells or tumors to grow. Some patients claim the hyperbaric oxygen makes them feel a lot more comfortable and functional after chemotherapy and also during healing. Note that some chemotherapy drugs are not to be used with hyperbaric oxygen, as the chemotherapy drugs can be enhanced and thus become toxic. A good hyperbaric oxygen facility (such as Bay Area Hyperbarics) will always call the chemotherapy manufacturer to ensure that hyperbaric oxygen therapy will be helpful and not damaging to the patient.
A physician would consider using hyperbaric chamber therapy under a variety of situations. Physicians most typically refer patients to hyperbarics when the patient is not healing with traditional medical interventions and hyperbaric chamber therapy is approved by Medicare for this condition.
Some patients experience significant unresolved pain and unremitting disease states that the mechanisms of hyperbaric oxygen therapy in a hyperbaric chamber are known to affect, such as the down regulation of inflamatory genes. For an example, some patients have experienced severe, unremitting hives with itching, which did not improve with any specialists interventions.
Some physicians will consider hyperbaric chamber therapy if the patient has no other good avenues for improving their failing health, and they know the hyperbaric chamber therapy is safe and will not harm the patient.
The CPT code for HBOT is G0277.
Hyperbaric Oxygen Therapy (HBOT) Hyperbaric Oxygen Therapy (HB0T) is a medical treatment where you inhale 100% oxygen in a chamber with increased atmospheric pressure. HBOT injects 400x the oxygen into your tissues and bones and mobilizes stem cells. It regrows healthy tissues in the brain, blood vessels, skin and bones. It also reduces pain and swelling, and speeds recovery.
It is simple, effective and painless.
Medicare covers Hyperbaric Oxygen Therapy for approved conditions, and many insurance companies also cover approved conditions. If your condition is not approved by your insurance, we can discuss our special rates. Give us a call at (408) 356–7438. We are happy to discuss your options with you.